“

Our hypothesis is that something is happening with MDMA that makes psychotherapy easier, so with a lower dose of MDMA in the active placebo, it might fool the subject or the therapist. And by giving people the option of following up with another half dose, it just extends the window for therapy rather than making it more intense.